“Near” Not Indefinite if Adequately Defined
Client Alert | 1 min read | 07.03.07
In Young v. Lumenis, Inc. (No. 06-1455; Fed. Cir. 2007), a Federal Circuit reverses a district court decision and holds that the term “near” is not indefinite in view of the specification.
In finding the patent claim indefinite under Section 112, second paragraph, the district court relied on prior case law for the principle that a word of degree, such as “near,” can be indefinite when it fails to distinguish the invention over the prior art and does not permit one of ordinary skill to know what activity constitutes infringement. However, the Federal Circuit distinguishes that case law, finding that the intrinsic evidence here provides ample guidance on the meaning of “near.” Unlike a situation in which “at least about” precedes a term that was defined in the specification only by a broad range, the Young panel finds that the patent specification describes a narrow window within which to practice the claimed method and, in that unique context, the term “near” adequately notifies the public as to what conduct will constitute infringement.
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief
